Global Product Portfolio

Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit and to learn about our generics and radiopharmaceutical products. Please note: Not all treatments are available in all countries.
Showing 70 results

fingolimod

canakinumab

ruxolitinib

ofatumumab

ribociclib

tisagenlecleucel

inclisiran

baclofen

gopzetotide

ranibizumab